We are live on ! Find out more
AC

Athanor Capital Portfolio holdings

AUM $24.6M
1-Year Est. Return 2.49%
This Fund
S&P 500
This Quarter Est. Return
+9.11%
1 Year Est. Return
+2.49%
3 Year Est. Return
+171.12%
5 Year Est. Return
+304.82%
10 Year Est. Return
–
AUM
$780M
AUM Growth
+$181M
Cap. Flow
+$153M
Cap. Flow %
19.67%
Top 10 Hldgs %
41.76%
Holding
156
New
91
Increased
29
Reduced
21
Closed
15

Top Buys

Rank Stock Value
1
APC
Anadarko Petroleum
APC
+$29.5M
2
NFLX icon
Netflix
NFLX
+$18.4M
3
MPC icon
Marathon Petroleum
MPC
+$16.8M
4
BABA icon
Alibaba
BABA
+$14.8M
5
MA icon
Mastercard
MA
+$13.7M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$16.8M
2
EMLC icon
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
+$11.7M
3
MU icon
Micron Technology
MU
+$10.1M
4
CRM icon
Salesforce
CRM
+$10.1M
5
GG
Goldcorp Inc
GG
+$9.15M

Sector Composition

Rank Sector Weight
1 Technology 21.51%
2 Communication Services 13.51%
3 Consumer Discretionary 9.86%
4 Financials 7.77%
5 Healthcare 4.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANAB icon
126
AnaptysBio
ANAB
$1.58B
$220K 0.03%
+3,900
New +$281K
BHVN
127
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$206K 0.03%
+4,700
New +$265K
EFX icon
128
Equifax
EFX
$20.3B
$203K 0.03%
+1,500
New +$188K
PS
129
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
$203K 0.03%
+6,700
New +$215K
SAGE
130
DELISTED
Sage Therapeutics
SAGE
$201K 0.03%
+1,100
New +$188K
ORTX
131
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$200K 0.03%
+1,430
New +$251K
TGTX icon
132
TG Therapeutics
TGTX
$7.96B
$198K 0.03%
+22,900
New +$173K
QTNT
133
DELISTED
Quotient Limited Ordinary Shares
QTNT
$182K 0.02%
+488
New +$174K
INFI
134
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$177K 0.02%
+98,400
New +$158K
MTEM
135
DELISTED
Molecular Templates, Inc.
MTEM
$169K 0.02%
+1,347
New +$146K
SNAP icon
136
Snap
SNAP
$7.89B
$167K 0.02%
+11,700
New +$143K
XOMA
137
DELISTED
Xoma
XOMA
$149K 0.02%
+10,000
New +$150K
RCUS icon
138
Arcus Biosciences
RCUS
$3.55B
$126K 0.02%
+15,900
New +$159K
SNDX icon
139
Syndax Pharmaceuticals
SNDX
$1.69B
$104K 0.01%
+11,200
New +$81.6K
FPRX
140
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$104K 0.01%
+17,300
New +$165K
XENE icon
141
Xenon Pharmaceuticals
XENE
$6.06B
$100K 0.01%
+10,100
New +$96.6K
AER icon
142
AerCap
AER
$23.7B
– –
-190,000
Closed -$8.84M
DD icon
143
DuPont de Nemours
DD
$18.5B
– –
-46,714
Closed -$6.31M
DK icon
144
Delek US
DK
$4.16B
– –
-205,364
Closed -$7.48M
FOX icon
145
Fox Class B
FOX
$21.8B
– –
-48,389
Closed -$1.74M
FOXA icon
146
Fox Class A
FOXA
$24.5B
– –
-94,943
Closed -$3.48M
LLY icon
147
Eli Lilly
LLY
$1.02T
– –
-129,404
Closed -$16.8M
LLY icon
148
PUT
Eli Lilly
LLY
$1.02T
– –
-130,000
Closed -$16.9M
LYFT icon
149
Lyft
LYFT
$6.02B
– –
-10,000
Closed -$783K
MPC icon
150
CALL
Marathon Petroleum
MPC
$92.4B
– –
-100,000
Closed -$5.99M
3 4 5
6
7

Similar funds

EGA
Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return
VH
Varley Holdings Tomago NSW, Australia $26.3M AUM
JM
Jeneq Management New York $22.3M AUM 47.87% 1-Year Est. Return
OA
Oakhurst Advisors Los Angeles, California $21.3M AUM 8.8% 1-Year Est. Return
HSCM
Hudson Structured Capital Management Stamford, Connecticut $28M AUM 36.23% 1-Year Est. Return
CCA
Cross Creek Advisors Salt Lake City, Utah $20.5M AUM 54.22% 1-Year Est. Return
ECM
Evolution Capital Management Crystal Bay, Nevada $29M AUM 2.56% 1-Year Est. Return
RCGV
Ribbit Capital GP V Palo Alto, California $19.8M AUM

Athanor Capital's Q2 2019 Portfolio in Review

As of Q2 2019, Athanor Capital held 156 positions worth $780M, up 30% from $599M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Athanor Capital deployed $153M of net new capital in Q2 2019, opening 91 new positions and adding to 29 existing holdings. Its largest new stake was Anadarko Petroleum: 439,700 shares worth $31M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Communication Services and Consumer Discretionary.

On the sell side, the largest reduction was VanEck JP Morgan EM Local Currency Bond ETF, an estimated $11.7M trimmed.

  • Athanor Capital's largest Q2 2019 buy was Anadarko Petroleum: 439,700 shares worth $31M.
  • Athanor Capital added most to Netflix in Q2 2019, an estimated $18.4M increase.
  • Athanor Capital's biggest Q2 2019 reduction was VanEck JP Morgan EM Local Currency Bond ETF, cutting an estimated $11.7M.
  • Athanor Capital fully exited Eli Lilly in Q2 2019, selling an estimated $16.8M.
  • Athanor Capital's ten largest holdings make up 42% of its $780M portfolio in Q2 2019.
  • Athanor Capital opened 91 new positions and closed 15 in Q2 2019.
  • Athanor Capital's portfolio value rose 30% quarter-over-quarter to $780M.

Based on Athanor Capital's 13F filing for Q2 2019, filed 13 Aug 2019.